• Explore /
  • Poster
  • / T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC).

T-cell receptor pharmacodynamics associated with survival and response to tremelimumab (T) in combination with durvalumab (D) in patients (pts) with unresectable hepatocellular carcinoma (uHCC).

Abstract Poster

Authors

null

Patricia McCoon

Translational Medicine, AstraZeneca, Waltham, MA

Patricia McCoon , Young S Lee , Robin Kate Kelley , Violeta Beleva Guthrie , Song Wu , Stephanie A Bien , Alejandra Negro , Philip He , John Kurland , J Carl Barrett , Fernanda Pilataxi , Steven Ching , Ghassan K. Abou-Alfa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT02519348

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4087)

DOI

10.1200/JCO.2021.39.15_suppl.4087

Abstract #

4087

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Xuyang Song

First Author: Oxana V. Crysler

First Author: Ghassan K. Abou-Alfa

First Author: Ghassan K. Abou-Alfa